>>>...... when there is a more recent Q1 2023 Sales figure, $158,077, available<<<
For one whole quarter this 'publicly' traded company with numerous USA FDA CLEARANCES did a putrid $158,000 in sales. And stockholders are supposed to get excited at that? THAT quarter being the most 'recent' sales the stockholders know about. This now is the first quarter 2024, one year after that quarter. Are we to believe that the sales are much better? One would have to believe that if sales were better, they would not withhold them from the 'public'.The market knows this is a joke, thus the laughable VERY LOW triple zero stock price. Funny how the select few left here, do not not see that.